Drp1 inhibition also sensitised malignant melanoma, lung cancer and osteosarcoma cells to tumour necrosis factor–related apoptosis-inducing ligand (TRAIL)–mediated apoptosis through a caspase-dependent pathway [88]. The gene discussed is DNM1L; the disease is melanoma.